These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10543282)

  • 1. A cost analysis on the pattern of asthma prescribing in the UK.
    Neville RG; Pearson MG; Richards N; Patience J; Sondhi S; Wagstaff B; Wells N
    Eur Respir J; 1999 Sep; 14(3):605-9. PubMed ID: 10543282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
    Dasgupta R; Guest JF
    Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
    Price DB; Ben-Joseph RH; Zhang Q
    Respir Med; 2001 Jan; 95(1):83-9. PubMed ID: 11207023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of asthma maintenance medications in a veteran population.
    Lee CH; Verma P; Lee J; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):165-6. PubMed ID: 26702545
    [No Abstract]   [Full Text] [Related]  

  • 5. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
    Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
    Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
    Price D; Wirén A; Kuna P
    Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
    Dunlop W; Heron L; Fox G; Greaney M
    Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma.
    Rank MA; Liesinger JT; Branda ME; Gionfriddo MR; Schatz M; Zeiger RS; Shah ND
    J Allergy Clin Immunol; 2016 May; 137(5):1373-1379.e3. PubMed ID: 26506020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of asthma in resource-limited settings: role of low-cost corticosteroid/β-agonist combination inhaler.
    Chiang CY; Aït-Khaled N; Bissell K; Enarson DA
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):129-36. PubMed ID: 25574908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of asthma. Results of the 1998 German National Health Interview and Examination Survey].
    Langen U; Knopf H; Melchert HU
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):903-10. PubMed ID: 16927032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines and realities of asthma management. The Philadelphia story.
    Lang DM; Sherman MS; Polansky M
    Arch Intern Med; 1997 Jun; 157(11):1193-200. PubMed ID: 9183230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
    Thomas M; Kocevar VS; Zhang Q; Yin DD; Price D
    Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic review of medical management of persistent asthma.
    Cheng JW; Arnold RJ
    Allergy Asthma Proc; 2008; 29(2):109-22. PubMed ID: 18430307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate prescribing in asthma and its related cost in east London.
    Naish J; Sturdy P; Toon P
    BMJ; 1995 Jan; 310(6972):97-100. PubMed ID: 7833736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists.
    Stempel DA; Durcannin-Robbins JF; Hedblom EC; Woolf R; Sturm LL; Stempl AB
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):153-8. PubMed ID: 8595534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current recommendation for asthma treatment].
    Kuna P
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():24-9. PubMed ID: 15524009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which patients are prescribed inhaled anti-asthma drugs?
    Roberts SJ; Bateman DN
    Thorax; 1994 Nov; 49(11):1090-5. PubMed ID: 7831622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.